Abstract:On the basis of biological activities of the ethyl acetate extracts of four Xenorhabdus sp., including Xenorhabdus nematophila FUM 220, Xenorhabdus nematophila FUM 221, Xenorhabdus bovienii FUM 222, and Xenorhabdus bovienii FUM 223, X. nematophila FUM 220 was preferentially selected to track the isolation of responsible compounds. Chemical study on the ethyl acetate extract of X. nematophila isolate FUM220 which is derived from the native nematode Steinernema carpocapsae (Rhabditida: Steinernematidae), was evaluated, and eleven compounds, including xenocoumacin II (1), xenortide-396 (2), xenortide A (3), xenortide-410 (4), xenortide-449 (5), xenematide A 663 (6), rhabdopeptide-574 (7), rhabdopeptide-588 (8), rhabdopeptide-687 (9), rhabdopeptide-701 (10), and nematophin-273 (11) were characterized. In this experimental study, we surveyed the antitumoral potential of bacterial extract and bacterial metabolites to treat human breast cancer (MCF-7), human lung cancer (A549), and murine Tumor (B16) cell lines. We observed that all samples were cytotoxic, but bacterial extracts of X. nematophila FUM 220 and X. bovienii FUM 223 showed higher toxicity on mentioned cell lines. Potent cytotoxic activity was found for compounds 6 and 11 with IC50 of 6.2 mu g/ml against human lung cancer A549 cell lines, too. These compounds showed moderated antibacterial activity against Xanthomonas oryzae pv. oryzae strain Xoo-IR42 (Xanthomonadales: Xanthomonadaceae) (MIC of 62.5 mu g/ml) and Staphylococcus aureus strain 1112 (Bacillales: Staphylococcaceae) (MIC of 100 mu g/ml). The bacterial extracts from X. bovienii FUM 222 showed strong inhibition of the growth of S. aureus strain 1112, by a minimal inhibitory concentration assay (MIC of 53.5 mu g/ml). Xenorhabdus genera produce metabolites with potent cytotoxic and antibacterial activity. Single compounds can be isolated, identified, and commercialized, but various species or strains may change their anticancer or antimicrobial potential. The present study brings new clues regarding the qualified of Xenorhabdus as future peptide sources for supplying natural bioactive compounds and challenge multidrug-resistant bacteria, treat cancer, and plant diseases.

Isolation, Identification, and Biological Characterization of 6 Secondary Metabolites Extracted from Myxococcus Xanthus 095B06

Secondary Metabolites Produced by Myxococcus sp.189B05

Cyclic Depsipeptides and Linear Peptides with Cytotoxic and Antiphytopathogenic Activities from Symbiotic Bacteria Ofxenorhabdus(enterobacteriales: Morganellaceae) Genus

Screening and Identification of Myxobacterias with Antifungal Activity

Isolation and Identification of Antibacterial Bioactive Compounds From Bacillus megaterium L2

Secondary Metabolites from the Mangrove Soil Derived Fungus Xylariaceae Sp. SCSIO41212

Secondary metabolites from Penicillium sp. 8PKH isolated from deteriorated rice straws

Secondary Metabolites from the Mangrove-derived Fungus Trichoderma Sp.

Isolating,purifying and detecting of activity of secondary metabolitie produced by myxobacteria 93431

Isolation, identification and antimicrobial activities of two secondary metabolites of Talaromyces verruculosus

Studies on the Cytotoxic Constituents from Marine Actinomycete Micromonospora Sp.(m2dg17)

Isolation and identification of erythromycin analogues produced by Saccharopolyspora sp. YIM M13568 from mangrove rhizophere soil in Hainan Province

Isolation and structure elucidation of the antibacterial metabolites from marine-derived Penicillium strain XGH2321

Study on the Antifungal Activity of Intracellular Secondary Metabolic Products from Xenorhabdus Nematophilus

Isolation of Secondary Metabolites with Antimicrobial Activities from Bacillus amyloliquefaciens LWYZ003

Isolation and identification of secondary metabolites from marine-derived actinomycete WBF16

Bioassay-Based Screening of Myxobacteria Producing Antitumor Secondary Metabolites

Study of Agro-Active Metabolites of Marine Actinomycete Y-0117

Isolation and characterization of an antimicrobial endophytic bacterium ME-2 from mulberry twig in China

[Secondary metabolites of endophyte fungi Xylaria sp. from Coptis chinensis].

Screening of myxobacteria strains producing bioactive substances against breast cancer